Longfellow Investment Management’s Apellis Pharmaceuticals APLS Stock Holding History

Longfellow Investment Management’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,860	Closed	-$74.8K	–	247
2026 Q1	$74.8K	Buy	+1,860	New	+$40.1K	0.02%	142

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Longfellow Investment Management's APLS Position: Q2 2026 in Review

Longfellow Investment Management sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 1,860 shares — an estimated $74.8K sold.

Longfellow Investment Management first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $74.8K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Longfellow Investment Management reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Longfellow Investment Management sold 1,860 Apellis Pharmaceuticals shares in Q2 2026, an estimated $74.8K.
Longfellow Investment Management first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Longfellow Investment Management's Apellis Pharmaceuticals position peaked at $74.8K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Longfellow Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.